Focused on transformative treatment technologies in dermatology and oncology.
The Company's current focus is a range of dermatological applications utilising its unique formulation and delivery technologies to meet currently unmet needs in the skincare market.
Result of General Meeting
Proactive TV Interview: Tim McCarthy - Increased Commercial Order and Analyst Research Note
Incanthera’s Skin+CELL rollout underpins ‘bright outlook’ for dermatology group